ELIZABETH SHPALL to Patient Reported Outcome Measures
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Patient Reported Outcome Measures.
Connection Strength
0.264
-
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. Br J Haematol. 2023 05; 201(4):738-746.
Score: 0.139
-
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies. Transplant Cell Ther. 2021 11; 27(11):930.e1-930.e10.
Score: 0.125